Measuring mRNA Levels in Breast Cancer Using PCR
Author Information
Author(s): JMS Bartlett, MJ Hulme, WR Miller
Primary Institution: University Department of Surgery, Glasgow Royal Infirmary; ICRF Medical Oncology Unit, Western General Hospital
Hypothesis
Can quantitative PCR be effectively used to measure mRNA levels of cAMP RI alpha in breast cancer samples?
Conclusion
The study established that quantitative PCR can accurately measure mRNA levels in breast cancer, demonstrating significant changes in expression.
Supporting Evidence
- Quantitative PCR demonstrated clear changes in mRNA levels in patient samples.
- The technique showed intra-assay variations of 16.2% and interassay variations of 9.3%.
- Values altered by 50% or more represent true changes in mRNA levels.
- Six out of twelve patients showed significant decreases in RI alpha mRNA during treatment.
Takeaway
This study shows that scientists can use a special test called PCR to see how much of a certain gene is in breast cancer samples, which can help doctors understand the disease better.
Methodology
The study used quantitative PCR to measure mRNA levels, validating the technique with quality control measures.
Limitations
The technique may not clearly separate values that vary by less than 50% within assays.
Participant Demographics
Breast cancer patients, specific demographics not provided.
Statistical Information
P-Value
p<0.05
Confidence Interval
95%
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website